ArticleJournal of pain research2025
Circulating MicroRNA Biomarkers for Chronic Pain and Acupuncture Response: An Exploratory High-Dimensional Small-Sample Study.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- New insight into RNA biomarkers in neuropathic pain: a clinician-neuroscientist roadmap to translational testing and treatment monitoring a clinical review.Frontiers in pain research (Lausanne, Switzerland) · 2026Review
- Artificial intelligence-based miRNA analysis for precision oncology: diagnostic and prognostic insights.Frontiers in molecular biosciences · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic pain involves complex neuroplastic changes and neuroinflammatory processes that may be reflected in circulating microRNA profiles. Acupuncture analgesia operates through multiple neurobiological mechanisms including modulation of neurotransmitter release and synaptic plasticity. High-dimensional small-sample (HDSS) datasets pose significant challenges for biomarker discovery in clinical omics studies, where the number of features vastly exceeds sample size. Existing approaches often lack robust validation frameworks, leading to overfitted models with poor generalizability. We developed and validated a comprehensive framework for HDSS biomarker discovery, demonstrated on circulating microRNA data from a chronic neck pain acupuncture trial. Our objective was to establish a simulation-validated pipeline that addresses preprocessing instability, model selection uncertainty, and statistical significance assessment in extreme HDSS scenarios. Methods: In this exploratory high-dimensional small-sample study, we analyzed plasma microRNA profiles from 6 participants in a chronic neck pain acupuncture trial, generating 9 paired measurements of microRNA fold-changes and pain reduction (ΔVAS) across baseline, 4-week, and 8-week time points. Our framework integrated: (1) robust preprocessing with Winsorization, arcsinh transformation, and median/MAD scaling; (2) nested leave-one-out cross-validation with LASSO/Elastic Net regularization; (3) permutation testing (10,000 iterations); and (4) comprehensive HDSS factorial simulation (19,440 runs across varying sample sizes, sparsity, signal-to-noise ratios, and preprocessing strategies). Results: The observed model achieved MAE=10.58, RMSE=13.70, and Spearman Conclusion: We present a rigorously validated framework for HDSS biomarker discovery that demonstrates modest but statistically significant predictive signal in extremely challenging conditions. This methodology is broadly applicable to other HDSS omics problems where traditional validation approaches fail.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.